Misoprostol for postpartum hemorrhage: Moving from evidence to practice

International Journal of Gynecology and Obstetrics

Volumn 116, Issue 1, 2012, Pages 1-3

  Starrs, Ann ^a   Winikoff, Beverly ^b  

^a Family Care International   (United States)

^b GYNUITY HEALTH PROJECTS   (United States)

Author keywords

Misoprostol; Postpartum hemorrhage; Prevention; Treatment

Indexed keywords

MISOPROSTOL;

ARTICLE; CLINICAL RESEARCH; EVIDENCE BASED PRACTICE; HEALTH CARE POLICY; MATERNAL CARE; MATERNAL MORTALITY; POSTPARTUM HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REGISTRATION; RISK BENEFIT ANALYSIS; STOMACH ULCER; THERAPEUTIC MISCONCEPTION; TREATMENT INDICATION;

EID: 83055186482     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2011.10.005     Document Type: Article

References (12)

1. World Health Organization WHO Model List of Essential Medicines 17th list. March 2011. Available at: http://www.who.int/medicines/publications/ essentialmedicines/en/
2. International Confederation of Midwives, International Federation of Gynecology and Obstetrics Prevention and Treatment of Post-partum Haemorrhage: New Advances for Low Resource Settings. Joint Statement Int J Gynecol Obstet 97 2 2007 160 163
3. American College of Obstetricians and Gynecologists ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists Number 76, October 2006: postpartum hemorrhage Obstet Gynecol 108 4 2006 1039 1047
4. Royal College of Obstetricians and Gynaecologists Green-top Guideline No. 52. May 2009 2009 RCOG Press London Available at: http://www.rcog.org.uk/files/ rcog-corp/GT52PostpartumHaemorrhage0411.pdf
5. R.J. Derman, B.S. Kodkany, S.S. Goudar, S.E. Geller, V.A. Naik, and M.B. Bellad Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial Lancet 368 9543 2006 1248 1253 (Pubitemid 44485797)
6. N. Mobeen, J. Durocher, N.F. Zuberi, N. Jahan, J. Blum, and S. Wasim Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial BJOG 118 3 2011 353 361
7. B. Winikoff, R. Dabash, J. Durocher, E. Darwish, T.N. Nguyen, and W. Leon Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial Lancet 375 9710 2010 210 216
8. J. Blum, B. Winikoff, S. Raghavan, R. Dabash, M.C. Ramadan, and B. Dilbaz Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial Lancet 375 9710 2010 217 223
9. M. Widmer, J. Blum, G.J. Hofmeyr, G. Carroli, H. Abdel-Aleem, and P. Lumbiganon Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial Lancet 375 9728 2010 1808 1813
10. Gynuity Health Projects The Product Problem: Pathways for Making Misoprostol Available for Postpartum Hemorrhage Meeting Report. March 24-25, 2011 2011 Gynuity Health Projects New York
11. Family Care International Mapping Misoprostol for Postpartum Hemorrhage: Organizational Activities, Challenges, and Opportunities 2011 Family Care International New York Available at: http://familycareintl.org/blog/wp-content/ uploads/2011/06/Mapping-FINAL-SM.pdf
12. H. Rushwan Misoprostol: An essential medicine for managing postpartum hemorrhage in low-resource settings? Int J Gynecol Obstet 114 3 2011 209 210